ISSN:
1573-0646
Keywords:
mitoxantrone
;
adenoid cystic carcinoma
;
dihydroxyanthracenedione
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
,
Medicine
Notes:
Summary Eighteen patients are evaluable for response in a Phase II trial of Mitoxantrone for advanced adenoid cystic carcinoma of the head and neck. One patient had a complete response; there were no partial responses. Twelve patients had stable disease for 3 or more months. There was no significant anti-tumor activity of Mitoxantrone in the group of patients with adenoid cystic carcinoma, all of whom were previously heavily treated with surgery, chemotherapy and/or radiation therapy.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00216934
Permalink